Zinc involvement in opioid addiction and analgesia – should zinc supplementation be recommended for opioid-treated persons?

INTRODUCTION: Zinc chelators were shown to facilitate some opioid-withdrawal signs in animals. Zinc deficiency, which affects more than 15 % the world’s population, is also common among opioid consumers and opioid-treated animals exhibit misbalances of zinc distribution. AIM: The present study focus...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciubotariu, Diana, Ghiciuc, Cristina Mihaela, Lupușoru, Cătălina Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523930/
https://www.ncbi.nlm.nih.gov/pubmed/26238243
http://dx.doi.org/10.1186/s13011-015-0025-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523930/
https://www.ncbi.nlm.nih.gov/pubmed/26238243
http://dx.doi.org/10.1186/s13011-015-0025-2

Ejemplares similares